Miles AK - Search Results

1

The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2.

Abdel-Fatah TMA, Rees RC, Pockley AG, Moseley P, Ball GR, Chan SYT, Ellis IO, Miles AK. Abdel-Fatah TMA, et al. Among authors: miles ak. Oncotarget. 2017 Nov 18;8(68):112245-112257. doi: 10.18632/oncotarget.22496. eCollection 2017 Dec 22. Oncotarget. 2017. PMID: 29348822 Free PMC article.

2

Identification of tumour antigens by serological analysis of cDNA expression cloning.

Li G, Miles A, Line A, Rees RC. Li G, et al. Cancer Immunol Immunother. 2004 Mar;53(3):139-43. doi: 10.1007/s00262-003-0471-y. Epub 2004 Jan 13. Cancer Immunol Immunother. 2004. PMID: 14722670 Free PMC article. Review.

3

Immunity to tumour antigens.

Li G, Ali SA, McArdle SE, Mian S, Ahmad M, Miles A, Rees RC. Li G, et al. Curr Pharm Des. 2005;11(27):3501-9. doi: 10.2174/138161205774414583. Curr Pharm Des. 2005. PMID: 16248804 Review.

4

The identification of human tumour antigens: Current status and future developments.

Miles AK, Matharoo-Ball B, Li G, Ahmad M, Rees RC. Miles AK, et al. Cancer Immunol Immunother. 2006 Aug;55(8):996-1003. doi: 10.1007/s00262-005-0115-5. Epub 2006 Jan 12. Cancer Immunol Immunother. 2006. PMID: 16408215 Free PMC article. Review.

5

Identification of a novel prostate cancer-associated tumor antigen.

Miles AK, Rogers A, Li G, Seth R, Powe D, McArdle SE, McCulloch TA, Bishop MC, Rees RC. Miles AK, et al. Prostate. 2007 Feb 15;67(3):274-87. doi: 10.1002/pros.20520. Prostate. 2007. PMID: 17192878

6

Serum biomarker profiling in cancer studies: a question of standardisation?

Matharoo-Ball B, Miles AK, Creaser CS, Ball G, Rees R. Matharoo-Ball B, et al. Among authors: miles ak. Vet Comp Oncol. 2008 Dec;6(4):224-47. doi: 10.1111/j.1476-5829.2008.00171.x. Vet Comp Oncol. 2008. PMID: 19178682 Review.

7

Cancer/testis antigens for therapeutic use.

Mathieu MG, Miles AK, Li G, McArdle SE, Rees RC. Mathieu MG, et al. Among authors: miles ak. J BUON. 2009 Sep;14 Suppl 1:S97-102. J BUON. 2009. PMID: 19785076 Review.

8

Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI-TOF mass spectrometry/bioinformatic approach.

Matharoo-Ball B, Ratcliffe L, Lancashire L, Ugurel S, Miles AK, Weston DJ, Rees R, Schadendorf D, Ball G, Creaser CS. Matharoo-Ball B, et al. Among authors: miles ak. Proteomics Clin Appl. 2007 Jun;1(6):605-20. doi: 10.1002/prca.200700022. Proteomics Clin Appl. 2007. PMID: 21136712

9

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

Dunning NL, Laversin SA, Miles AK, Rees RC. Dunning NL, et al. Among authors: miles ak. Cancer Immunol Immunother. 2011 Aug;60(8):1181-93. doi: 10.1007/s00262-011-1065-8. Epub 2011 Jun 19. Cancer Immunol Immunother. 2011. PMID: 21688178 Free PMC article. Review.

10

Expression of the tumour antigen T21 is up-regulated in prostate cancer and is associated with tumour stage.

Miles AK, Rogers A, McCulloch T, Hodi Z, McArdle S, Bishop M, Rees RC. Miles AK, et al. BJU Int. 2012 Mar;109(5):796-805. doi: 10.1111/j.1464-410X.2011.10407.x. Epub 2011 Aug 18. BJU Int. 2012. PMID: 21851547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page